Mexico's pharmaceuticals market forecast to grow to $14.9 billion by 2014

6 January 2010

By end 2009, the pharmaceutical market in Mexico will have reached a value of 114.8 billion Mexican pesos ($8.6 billion), up from 109.1 billion pesos in 2008. Growth will continue to 2014, reaching 153.2 billion pesos ($14.9 billion), according to a new review of the market from Business Monitor International.

Per-capita drug spending will rise from $79 in 2009 to $133 by 2014. While the rising population should drive demand, BMI notes that the patterns of drug spending in Mexico are changing.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK